AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 29,448 | 760 | 0 | 0 | 0 |
| Gross Profit | 29,448 | 760 | N/A | N/A | N/A |
| Operating Expenses | 21,049 | 23,936 | 22,940 | 20,763 | 17,504 |
| Operating Income | 8,399 | -23,177 | -22,940 | -4,276 | -17,504 |
| Interest Expense | 38 | 38 | 41 | 32 | 29 |
| Other Income | -2,003 | -1,952 | 2,563 | -1,311 | 398 |
| Pre-tax Income | 6,359 | -25,166 | -20,418 | -5,619 | -17,136 |
| Income Tax | N/A | N/A | N/A | 8 | -3 |
| Net Income Continuous | 6,359 | -25,166 | -20,418 | -5,627 | -17,132 |
| Net Income | $6,359 | $-25,166 | $-20,418 | $-5,620 | $-17,139 |
| EPS Basic Total Ops | 0.07 | -0.25 | -0.21 | -0.06 | -0.20 |
| EPS Basic Continuous Ops | 0.06 | -0.25 | -0.21 | -0.06 | -0.20 |
| EPS Diluted Total Ops | 0.06 | -0.25 | -0.21 | -0.06 | -0.20 |
| EPS Diluted Continuous Ops | 0.06 | -0.25 | -0.21 | -0.06 | -0.20 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.25 | -0.21 | N/A | N/A |
| EBITDA(a) | $9,066 | $-22,592 | $-22,304 | $-20,175 | $-16,862 |